|
Workshop
[Free Online workshop] Immunogenicity of Biologic Drugs – Clinical Relevance case studies, Predictive Tools & Challenges with New modalities
Speakers:
Organizers:
Ola Saad & Sivan Cohen (Genentech, Inc.)
Date:
2022-09-15- 09/16/2022
Time:
8:30-12:30 Pacific Time
Registration fee:
Free
Location:
Online via zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2022-09-14
(it will close sooner if the seating cap is reached)
About the Topic
The Immunogenicity of Biologic Drugs workshop is a 2 half-day program aimed to promote the discussion and exchange of scientific ideas from the FDA and leading industry and academic experts on the application and clinical relevance of immunogenicity mitigation and assessment assays. Tentative topics covered in this workshop include, but are not limited to:
-
ADA assay Development, Validation, and interpretation (drug and target interference, pre-existing antibodies)
-
Advancements of predictive immunogenicity risk tools (in vitro, in silico) and lessons learned with implementation
-
Bioanalytical Strategies for New Modalities
-
Highlights from and comments around 2022 FDA Immunogenicity Labeling Draft Guidance
About the Speakers- Steve Swanson (Senior Principal Scientist, Genentech)
- Yi Wen (Research Advisor/Leader, Eli Lilly)
- Francesca Civoli (Vice President Bioanalytical Sciences, Coherus BioSciences)
- Vibha Jawa (Executive Director, BMS)
- Wenyu Liu (Senior Scientist, Genentech)
2022-07-27, [Free Online Symposium] Success Stories and Lessons Learned from Recent FDA Approvals: VOXZOGO (vosoritide) by BioMarin Pharmaceutical Inc.
|
2022-08-17, [Free Online Symposium] Advances in Oncology
|
2022-11-02, [Free Online workshop] Bispecific Antibodies: Discovery, Engineering, Development and Regulatory Considerations
|
2022-11-14, [Free Online Symposium] Advances in Cell therapy
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Hypha Discovery
Synthesis, purification & NMR characterization of phase 1 and 2 drug metabolites at mg-g scale with COAs. Also experts in natural products.
|
Laviana Pharma Corp
Laviana’s new GMP facility will be validated very soon! We’re taking bookings for API, Intermediate & Custom Synthesis and R&D services for Q2-2023
|
Alturas Analytics, Inc.
Expert GLP & non-GLP LC-MS/MS, GC-MS/MS bioanalytical & PK/TK analysis services of small & large molecules in any matrix. Discovery through phase IV.
|
Veloxity Labs, LLC
The unique employee-owned LC-MS/MS bioanalytical CRO with >100 years of experience and the responsiveness of a start-up! GLP and non-GLP.
|
Submit a Text Ad
|